FDA Approved: NARATRIPTAN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Naratriptan from Hikma Pharmaceuticals USA Inc. under ANDA090381, enabling the marketing of a generic Naratriptan pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Naratriptan (Naratriptan)

Snippet

SUPPL AP for NARATRIPTAN (NARATRIPTAN)